Loading…
NorthStar Medical Radioisotopes has signed an agreement to purchase two additional Rhodotron TT300 HE electron beam accelerators from IBA for the production of molybdenum-99 at its Beloit, Wisconsin headquarters. This brings the total to five accelerators purchased from IBA.
NorthStar Medical Radioisotopes and IBA expanded their collaboration to enable global availability of technetium-99m (Tc-99m) using NorthStar's non-uranium based Mo-99 produced with IBA accelerators. The expansion builds on an existing contract for up to eight Rhodotron accelerators.